Intermediate Stage Hepatocellular Carcinoma: A Summary Review
[Journal of Hepatocellular Carcinoma]
Diagnosis & Disease Information
Lenalidomide Maintenance Therapy May Be Best Treatment for Newly Diagnosed Multiple Myeloma
A meta-analysis of 11 studies rated the efficacy of 8 maintenance therapies with lenalidomide in combination or as monotherapy for NDMM.
Early Checkpoint Inhibition With Cytotoxic Chemotherapy Improves OS, PFS in Extensive-Stage SCLC
In this randomized, double-blind, placebo-controlled study, researchers sought to determine the effect of including a checkpoint inhibitor in induction therapy for patients with extensive-stage small cell lung cancer.
Triplet Regimen Found Most Effective for Relapsed/Refractory Multiple Myeloma
An updated network meta-analysis found that a triplet regimen consisting of lenalidomide and dexamethasone plus an immunotherapeutic agent had better efficacy in terms of NRR, TTP, PFS, and OS than other regimens.
Rituximab Maintenance Improved Long-Term Survival in Elderly With Follicular Lymphoma
A retrospective analysis of outcomes demonstrated the influence of rituximab maintenance after R-CHOP or R-CVP for follicular lymphoma in elderly patients.
Lenalidomide Plus R-CHOP Effective in High-Burden Follicular Lymphoma
A phase 2 study was conducted to determine the effectiveness of adding lenalidomide to R-CHOP as a first-line treatment for high-burden follicular lymphoma.
Involved-Field Radiotherapy Plus Chemotherapy Prolonged PFS in Follicular Lymphoma
Although involved-field radiotherapy (IFRT) has a high level of disease control in patients with follicular lymphoma, relapse frequently occurs; therefore, researchers sought to determine if adding chemotherapy would improve progression-free survival.
Combined Microwave Ablation and Minimally Invasive Open Decompression for the Management of Thoracic Metastasis in Breast Cancer
[Cancer Management and Research] An investigation into the efficacy of microwave ablation and minimally invasive open decompression treatment for breast cancer with thoracic metastases.
Ixazomib, Lenalidomide, Dexamethasone Effective But Increases Toxicity in Multiple Myeloma
Three-drug regimen twice a week achieved good response and long-term outcomes in patients with newly diagnosed multiple myeloma; however, regimen has higher toxicity than once weekly dose.
Andrographolide Potentiates the Antitumor Effect of Topotecan in Acute Myeloid Leukemia Cells Through an Intrinsic Apoptotic Pathway
[Cancer Management and Research] In this study, researchers explored the potential of andrographolide and topotecan, separately and together, in the in vitro treatment of the U937 acute myeloid leukemic cell line.
- Loading...
Loading...
Next post in Leukemia
Loading... 
Loading...